drugset / Trial / NCT01352702

Impact of Dabigatran and Phenprocoumon on Clopidogrel Mediated ADP Induced Platelet Aggregation in Patients With Atrial Fibrillation

NCT01352702

Phase 4 Terminated 46 enrolled German Heart Center Munich
RandomizedParallel-groupOpen-labelTreatment

Summary

The aim of this study is to evaluate whether dabigatran reduces clopidogrel mediated ADP induced platelet aggregation measured by MEA as compared to phenprocoumon after a two-week treatment with either agent.

Timeline

Start
2011-05
Primary completion
2014-05
Completion
2014-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Dabigatran Unknown Oral
Comparator Phenprocoumon Small molecule Oral